Business
Brooks Automation Reports its Fourth Quarter and Year-End Results of Fiscal 2020, Ended September 30, 2020, and Announces Quarterly Cash Dividend
Significant Earnings Growth Driven by Operating Margin Expansion and Double-Digit Revenue Growth in Both Life Sciences and Semiconductor Solutions CHELMSFORD,
About this update from Azenta, Inc.
[{"type":"text","content":"Significant Earnings Growth Driven by Operating Margin Expansion and Double-Digit Revenue Growth in Both Life Sciences and Semiconductor Solutions\n\n\nCHELMSFORD, Mass., Nov. 10, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the fourth fiscal quarter and fiscal year, ended September 30, 2020.\nFinancial Results Summary\nQuarter Ended\nYear Ended \nDollars in millions, except per share data\nSeptember 30, \nSeptember 30, \nSeptember 30, \nSeptember 30, \n2020\n2019\nChange\n2020\n2019\nChange\nRevenue\n$\n246\n$\n199\n24\n%\n$\n897\n$\n781\n15\n%\nSemiconductor Solutions \n$\n138\n$\n105\n31\n%\n$\n509\n$\n447\n14\n%\nLife Sciences \n$\n108\n$\n94\n15\n%\n$\n389\n$\n334\n16\n%\nDiluted EPS Continuing Operations\n$\n0.39\n$\n0.07\n447\n%\n$\n0.88\n$\n0.13\n567\n%\nDiluted EPS Total\n$\n0.39\n$\n5.68\nNM\n$\n0.88\n$\n6.04\nNM\nNon-GAAP Diluted EPS Continuing Operations\n$\n0.47\n$\n0.23\n100\n%\n$\n1.26\n$\n0.76\n65\n%\nAdjusted EBITDA\n$\n54\n$\n31\n75\n%\n$\n161\n$\n128\n26\n%\nManagement Comments \"We delivered a robust quarter and completed a milestone year for the company,\" commented Steve Schwartz, President and CEO. \"The Semiconductor Solutions and Life Sciences businesses each continued their momentum during the quarter, once again achieving operating margin expansion and delivering double-digit growth for the year. The growth is proof of our ability to lead and service two markets that have remained robust in spite of the pandemic. Our global team's dedication and our business model's strength keeps us positioned to address the ever-changing challenges of these unprecedented times as we move into fiscal 2021.\" \nSummary of GAAP Results\nFourth Quarter, Fiscal 2020\nRevenue for the fourth fiscal quarter was $246 million, up 24% year over year. Diluted EPS from continuing operations was $0.39 per share compared to $0.07 per share in the fourth quarter of 2019. Life Sciences revenue of $108 million grew 15% year over year and 16% sequentially. Year-over-year organic growth was 17%. Life Science Products grew 20% year over year, and Life Science Services grew 12%. Organic revenue growth in Q4, from what was previously defined as Sample Management, was 14% year-over-year. Semiconductor Solutions revenue was $138 million, an increase of 31% year over year and 9% sequentially...